https://biotechmorning.com/news/generate-biomedicines-ipo-ai-drug-design Biotech Morning en 2026-04-26T14:11:42.460Z The $400M Bet That AI Can Design Better Drugs Than Humans https://biotechmorning.com/news/roche-oral-ms-pill-fenebrutinib Biotech Morning en 2026-04-26T14:11:00.100Z Roche Wants to Replace Your MS Infusion With a Tiny Pill https://biotechmorning.com/news/fda-cms-rapid-pathway-breakthrough-devices Biotech Morning en 2026-04-26T14:10:09.912Z The FDA Just Killed the Worst Wait in Medicine https://biotechmorning.com/news/fda-peptide-reclassification-compounding-pharmacies Biotech Morning en 2026-04-26T14:09:32.398Z The FDA Just Opened the Door for Peptide Pharmacies. Now What? https://biotechmorning.com/news/avalyn-pharma-200m-ipo-inhaled-lung-therapy Biotech Morning en 2026-04-26T14:08:51.618Z A $200M Bet That Breathing Your Medicine Beats Swallowing It https://biotechmorning.com/news/revolution-medicines-kras-undruggable-aacr-2026 Biotech Morning en 2026-04-26T14:08:04.368Z The 40-Year Quest to Drug Cancer's Most Stubborn Target May Finally Be Over https://biotechmorning.com/news/roche-nvidia-ai-factory-pharma Biotech Morning en 2026-04-26T14:07:15.623Z Roche Just Built Pharma's Biggest AI Brain. Here's Why It Matters. https://biotechmorning.com/news/alamar-biosciences-ipo-oversubscribed Biotech Morning en 2026-04-25T14:09:15.651Z The Protein-Reading Company Wall Street Couldn't Get Enough Of https://biotechmorning.com/news/white-house-fda-fast-track-psychedelics Biotech Morning en 2026-04-25T14:08:32.930Z The White House Just Told the FDA to Fast-Track Psychedelics https://biotechmorning.com/news/kailera-therapeutics-ipo-breaks-nasdaq-record Biotech Morning en 2026-04-25T14:07:51.913Z The $625M IPO That Just Broke Nasdaq Biotech Records https://biotechmorning.com/news/wcg-acquires-contract-network-clinical-trials Biotech Morning en 2026-04-25T14:07:12.640Z The Boring Part of Clinical Trials Just Got a Makeover https://biotechmorning.com/news/amneal-kashiv-biosimilar-manufacturing-deal Biotech Morning en 2026-04-25T14:06:33.300Z Amneal Just Bet $1.1 Billion That Making Biosimilars Is the Real Gold Rush https://biotechmorning.com/news/fda-fast-tracked-psychedelics-priority-review Biotech Morning en 2026-04-25T14:05:50.054Z The FDA Just Fast-Tracked Psychedelics. Yes, Really.